Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Emraclidine with placebo for people with Schizophrenia. Participants receive Emraclidine or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive active, then sham Intermittent Theta Burst Stimulation (iTBS) over DLPFC instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Resistance training programme can help people with Psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This observational study is following people with psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing LY03020 with placebo for people with Schizophrenia. Participants receive LY03020 or placebo and complete study visits and assessments.
This study is comparing Empagliflozin with Group 1 as control group for people with Sodium-glucose Transport Protein Two Inhibitor,Metabolic Deficits Caused by Antipsychotics. Participants receive Empagliflozin or Group 1 as control group and complete study visits and assessments.
This study is looking at whether a digital support tool can help people with Auditory Hallucinations or Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.
This study is looking at whether PEERS social skills intervention can help people with Autism Spectrum Disorder, Psychosis, or Social Communication. Participants take part in PEERS social skills intervention and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is looking at whether Magnetic Seizure Therapy (MST) can help people with Treatment Resistant Schizophrenia, Schizophrenia, or schizoaffective disorder. Participants take part in Magnetic Seizure Therapy (MST) and complete follow-up assessments.
This study is looking at care and outcomes for people with Heat Stress, Physiological Stress, or Cognitive Change. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether maintenance electroconvulsive therapy (mECT) can help people with Schizophrenia or Treatment Resistant Schizophrenia. Participants take part in maintenance electroconvulsive therapy (mECT) and complete follow-up assessments.
This study is looking at care and outcomes for people with Schizophrenia Disorder. Taking part may give some people access to a digital support tool, but direct benefit is not guaranteed.
This study is looking at whether Cognitive Enhancement Therapy can help people with Schizophrenia. Participants take part in Cognitive Enhancement Therapy and complete follow-up assessments.
This study is looking at evaluate the feasibility of Narrative Exposure Therapy (NET) for people experiencing psychosis for people with Psychosis or Schizophrenia and Other psychosis. Participants take part in the therapy or support program and complete follow-up questionnaires or assessments.
This study is looking at whether Clay therapy can help people with Schizophrenia and Related Disorders. Participants take part in Clay therapy and complete follow-up assessments.
This study is looking at whether a VR protocol simulating psychotic symptoms on explicit and implicit stigma works for people with Schizophrenia Disorder. Participants take part in the program and complete follow-up questionnaires or assessments.
This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is comparing Evenamide 15 mg bid with placebo for people with Treatment-resistant Schizophrenia. Participants receive Evenamide 15 mg bid or placebo and complete study visits and assessments.
This observational study is following people with Schizophrenia and Other psychosis, Cannabis Use Disorder, or Healthy to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.
This study is looking at whether Cannabidiol can help people with Dual Diagnosis. Participants take part in Cannabidiol and complete follow-up assessments.
This study is comparing Pediococcus acidilactici, pA1c®HI postbiotic supplementation taking participants with placebo for people with SCHIZOPHRENIA 1, Metabolic Abnormalities, or Postbiotic Supplement. Participants receive Pediococcus acidilactici, pA1c®HI postbiotic supplementation taking participants or placebo and complete study visits and assessments.
This study is looking at whether LB-102 can help people with Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.
This study is comparing Berberine with placebo for people with Schizophrenia or Negative Symptoms of Schizophrenia. Participants receive Berberine or placebo and complete study visits and assessments.